Agios Pharmaceuticals Inc
AGIOHealthcare|Biotechnology|USA
$41.23
-1.56 (-3.65%)
Tangible Book
$40.97
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (343)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gheuens Sarah | Chief Medical Officer | 2026-07-01 | SELL | 4,007 | $37.56 | $150.5K |
| Burns James William | Chief Legal Officer | 2026-04-02 | SELL | 3,280 | $34.71 | $113.8K |
| Gheuens Sarah | Chief Medical Officer | 2026-04-02 | SELL | 2,940 | $34.71 | $102K |
| Jones Cecilia | CFO | 2026-04-02 | SELL | 3,141 | $34.71 | $109K |
| Milanova Tsveta | Chief Commercial Officer | 2026-04-02 | SELL | 3,262 | $34.71 | $113.2K |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | 2026-04-02 | SELL | 2,959 | $34.71 | $102.7K |
| Goff Brian | CEO | 2026-04-02 | SELL | 19,068 | $34.71 | $661.9K |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | 2026-03-05 | SELL | 2,959 | $27.8 | $82.3K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2026-03-03 | SELL | 5,272 | $28.88 | $152.3K |
| Goff Brian | CEO | 2026-03-02 | SELL | 18,055 | $28.96 | $522.9K |
| Burns James William | Chief Legal Officer | 2026-03-02 | SELL | 5,218 | $28.96 | $151.1K |
| Gheuens Sarah | Chief Medical Officer | 2026-03-02 | SELL | 4,055 | $28.96 | $117.4K |
| Jones Cecilia | CFO | 2026-03-02 | SELL | 5,035 | $28.96 | $145.8K |
| Milanova Tsveta | Chief Commercial Officer | 2026-03-02 | SELL | 2,868 | $28.96 | $83.1K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2026-03-02 | SELL | 2,223 | $28.96 | $64.4K |
| Milanova Tsveta | Chief Commercial Officer | 2026-01-05 | SELL | 2,872 | $27.02 | $77.6K |
| Burns James William | Chief Legal Officer | 2025-12-30 | SELL | 2,932 | $27.09 | $79.4K |
| Goff Brian | CEO | 2025-12-30 | SELL | 18,703 | $27.09 | $506.7K |
| Gheuens Sarah | Chief Medical Officer | 2025-12-30 | SELL | 2,932 | $27.09 | $79.4K |
| Milanova Tsveta | Chief Commercial Officer | 2025-12-30 | SELL | 2,932 | $27.09 | $79.4K |
| Jones Cecilia | CFO | 2025-12-30 | SELL | 2,932 | $27.09 | $79.4K |
| Scadden David | Director | 2025-11-12 | SELL | 200 | $43.84 | $8.8K |
| Gheuens Sarah | Chief Medical Officer | 2025-11-11 | SELL | 2,454 | $43.78 | $107.4K |
| Gheuens Sarah | Chief Medical Officer | 2025-10-30 | SELL | 200 | $43.81 | $8.8K |
| Gheuens Sarah | Chief Medical Officer | 2025-10-27 | SELL | 3,302 | $43.92 | $145K |
| Scadden David | Director | 2025-10-08 | SELL | 200 | $41 | $8.2K |
| Scadden David | Director | 2025-09-30 | SELL | 200 | $40 | $8K |
| Jones Cecilia | CFO | 2025-09-26 | SELL | 3,651 | $36.77 | $134.2K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2025-09-05 | SELL | 8,546 | $36.87 | $315.1K |
| Scadden David | Director | 2025-08-27 | SELL | 200 | $40 | $8K |
| Goff Brian | CEO | 2025-08-08 | SELL | 11,085 | $36.67 | $406.5K |
| Scadden David | Director | 2025-07-10 | SELL | 1,400 | $40 | $56K |
| Gheuens Sarah | Chief Medical Officer | 2025-07-09 | SELL | 11,914 | $37.99 | $452.6K |
| Gheuens Sarah | Chief Medical Officer | 2025-07-01 | SELL | 4,091 | $34.17 | $139.8K |
| Burns James William | Chief Legal Officer | 2025-06-24 | SELL | 2,799 | $33.54 | $93.9K |
| Gheuens Sarah | Chief Medical Officer | 2025-06-24 | SELL | 2,909 | $33.54 | $97.6K |
| Jones Cecilia | CFO | 2025-06-24 | SELL | 1,780 | $33.54 | $59.7K |
| Milanova Tsveta | Chief Commercial Officer | 2025-06-24 | SELL | 2,770 | $33.54 | $92.9K |
| Goff Brian | CEO | 2025-06-24 | SELL | 18,700 | $33.54 | $627.2K |
| FOUSE JACQUALYN A | Director | 2025-04-10 | SELL | 7,497 | $25.9 | $194.2K |
| Milanova Tsveta | Chief Commercial Officer | 2025-03-03 | SELL | 1,681 | $35.54 | $59.7K |
| Burns James William | Chief Legal Officer | 2025-03-03 | SELL | 4,005 | $35.54 | $142.3K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2025-02-05 | SELL | 2,272 | $34.39 | $78.1K |
| Milanova Tsveta | Chief Commercial Officer | 2025-01-06 | SELL | 2,804 | $32.18 | $90.2K |
| Scadden David | Director | 2024-12-11 | SELL | 200 | $46.28 | $9.3K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-11-08 | SELL | 772 | $56.09 | $43.3K |
| Ballal Rahul D. | Director | 2024-11-08 | SELL | 20,000 | $55.86 | $1117.2K |
| Burns James William | Chief Legal Officer | 2024-11-07 | SELL | 21,752 | $52.21 | $1135.7K |
| Jones Cecilia | CFO | 2024-09-26 | SELL | 2,542 | $49.03 | $124.6K |
| Goff Brian | CEO | 2024-08-08 | SELL | 11,091 | $42.75 | $474.1K |
| Gheuens Sarah | Chief Medical Officer | 2024-07-01 | SELL | 3,705 | $43.85 | $162.5K |
| Goff Brian | CEO | 2024-06-05 | SELL | 12,115 | $48.84 | $591.7K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-06-03 | SELL | 1,362 | $44.39 | $60.5K |
| FOUSE JACQUALYN A | Director | 2024-04-10 | SELL | 7,791 | $27.55 | $214.6K |
| Foster-Cheek Kaye I | Director | 2024-03-07 | SELL | 1,285 | $31.62 | $40.6K |
| Foster-Cheek Kaye I | Director | 2024-03-06 | SELL | 4,715 | $32 | $150.9K |
| Burns James William | Chief Legal Officer | 2024-03-05 | SELL | 2,642 | $32.57 | $86K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-03-05 | SELL | 1,214 | $32.57 | $39.5K |
| Gheuens Sarah | Chief Medical Officer | 2024-03-05 | SELL | 2,642 | $32.57 | $86K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-03-05 | SELL | 1,913 | $31.75 | $60.7K |
| Schenkein David P | Director | 2024-02-27 | SELL | 69,329 | $34.67 | $2403.6K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-02-20 | SELL | 504 | $26.63 | $13.4K |
| Gheuens Sarah | Chief Medical Officer | 2024-02-14 | SELL | 642 | $25.14 | $16.1K |
| Burns James William | Chief Legal Officer | 2024-02-14 | SELL | 545 | $25.14 | $13.7K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2024-02-14 | SELL | 273 | $25.14 | $6.9K |
| Burns James William | Chief Legal Officer | 2024-01-24 | SELL | 1,708 | $21.64 | $37K |
| Gheuens Sarah | Chief Medical Officer | 2024-01-24 | SELL | 1,708 | $21.64 | $37K |
| Jones Cecilia | CFO | 2024-01-24 | SELL | 1,886 | $21.64 | $40.8K |
| FOUSE JACQUALYN A | Director | 2024-01-24 | SELL | 10,722 | $21.64 | $232K |
| Goff Brian | CEO | 2024-01-24 | SELL | 7,635 | $21.64 | $165.2K |
| Milanova Tsveta | Chief Commercial Officer | 2024-01-24 | SELL | 1,618 | $21.64 | $35K |
| Goff Brian | CEO | 2024-01-09 | SELL | 12,066 | $22.99 | $277.4K |
| FOUSE JACQUALYN A | Director | 2024-01-09 | SELL | 8,391 | $22.99 | $192.9K |
| Burns James William | Chief Legal Officer | 2024-01-09 | SELL | 1,163 | $22.99 | $26.7K |
| Gheuens Sarah | Chief Medical Officer | 2024-01-09 | SELL | 1,789 | $22.99 | $41.1K |
| Milanova Tsveta | Chief Commercial Officer | 2024-01-05 | SELL | 2,902 | $22.32 | $64.8K |
| Jones Cecilia | CFO | 2023-09-28 | SELL | 2,179 | $24.79 | $54K |
| Burns James William | Chief Legal Officer | 2023-08-17 | SELL | 6,395 | $26.28 | $168.1K |
| Foster-Cheek Kaye I | Director | 2023-08-09 | SELL | 25,000 | $25.96 | $649K |
| Goff Brian | CEO | 2023-08-08 | SELL | 10,178 | $25.48 | $259.3K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2023-08-07 | SELL | 2,918 | $25.39 | $74.1K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2023-08-01 | SELL | 1,232 | $26.26 | $32.4K |
| Burns James William | Chief Legal Officer | 2023-06-30 | SELL | 1,707 | $28.36 | $48.4K |
| FOUSE JACQUALYN A | Director | 2023-06-30 | SELL | 10,718 | $28.36 | $304K |
| Gheuens Sarah | Chief Medical Officer | 2023-06-30 | SELL | 1,707 | $28.36 | $48.4K |
| Goff Brian | CEO | 2023-06-30 | SELL | 11,449 | $28.36 | $324.7K |
| Jones Cecilia | CFO | 2023-06-30 | SELL | 1,597 | $28.36 | $45.3K |
| Milanova Tsveta | Chief Commercial Officer | 2023-06-30 | SELL | 1,618 | $28.36 | $45.9K |
| Schenkein David P | Director | 2023-04-03 | SELL | 16,363 | $22.85 | $373.9K |
| Schenkein David P | Director | 2023-03-27 | SELL | 20,000 | $22.15 | $443K |
| Schenkein David P | Director | 2023-03-13 | SELL | 20,000 | $22.49 | $449.8K |
| Schenkein David P | Director | 2023-02-27 | SELL | 20,000 | $25.37 | $507.4K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2023-02-16 | SELL | 233 | $27.21 | $6.3K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2023-02-14 | SELL | 504 | $28.59 | $14.4K |
| Schenkein David P | Director | 2023-02-13 | SELL | 20,000 | $28.62 | $572.4K |
| Schenkein David P | Director | 2023-01-30 | SELL | 20,000 | $29.33 | $586.6K |
| Schenkein David P | Director | 2023-01-17 | SELL | 20,000 | $28.85 | $577K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2022-02-25 | SELL | 108 | $30 | $3.2K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2022-02-16 | SELL | 233 | $30.81 | $7.2K |
| Washburn Theodore James Jr. | Principal Accounting Officer | 2022-02-14 | SELL | 504 | $31.25 | $15.8K |
| Alenson Carman | Principal Accounting Officer | 2021-06-21 | SELL | 1,777 | $61.61 | $109.5K |
| Bowden Christopher | Chief Medical Officer | 2021-06-10 | SELL | 28,002 | $60.09 | $1682.6K |
| Bowden Christopher | Chief Medical Officer | 2021-06-08 | SELL | 10,943 | $60.05 | $657.1K |
| Bowden Christopher | Chief Medical Officer | 2021-04-20 | SELL | 17,611 | $55.12 | $970.7K |
| Alenson Carman | Principal Accounting Officer | 2021-04-15 | SELL | 991 | $54 | $53.5K |
| Miles Darrin | Chief Commercial Officer | 2021-03-05 | SELL | 2,700 | $48.1 | $129.9K |
| Alenson Carman | Principal Accounting Officer | 2020-09-02 | SELL | 250 | $39.93 | $10K |
| Bowden Christopher | Chief Medical Officer | 2020-05-20 | SELL | 3,583 | $50.01 | $179.2K |
| Alenson Carman | Principal Accounting Officer | 2020-03-02 | SELL | 345 | $47.3 | $16.3K |
| Alenson Carman | Principal Accounting Officer | 2020-02-26 | SELL | 472 | $47.12 | $22.2K |
| Alenson Carman | Principal Accounting Officer | 2020-02-20 | SELL | 2,427 | $53.37 | $129.5K |
| Bowden Christopher | Chief Medical Officer | 2020-02-13 | SELL | 7,100 | $50.16 | $356.1K |
| Bowden Christopher | Chief Medical Officer | 2020-02-11 | SELL | 621 | $50.02 | $31.1K |
| Bowden Christopher | Chief Medical Officer | 2020-02-04 | SELL | 49,638 | $50.08 | $2485.9K |
| Alenson Carman | Principal Accounting Officer | 2019-12-26 | SELL | 2,950 | $50.09 | $147.8K |
| FOUSE JACQUALYN A | CEO | 2019-11-13 | BUY | 40,322 | $31 | $1250K |
| Schenkein David P | Director | 2019-11-13 | BUY | 8,064 | $31 | $250K |
| CELGENE CORP /DE/ | 10% Owner | 2019-11-12 | BUY | 403,225 | $31 | $12500K |
| Biller Scott | Chief Scientific Officer | 2019-04-05 | SELL | 3,000 | $67.71 | $203.1K |
| Bowden Christopher | Chief Medical Officer | 2019-04-01 | SELL | 10,000 | $66.57 | $665.7K |
| Bowden Christopher | Chief Medical Officer | 2019-03-15 | SELL | 10,000 | $64.16 | $641.6K |
| Biller Scott | Chief Scientific Officer | 2019-03-05 | SELL | 3,000 | $67.68 | $203K |
| Hoerter Steven L. | Chief Commercial Officer | 2019-03-04 | SELL | 10,000 | $67.01 | $670.1K |
| Biller Scott | Chief Scientific Officer | 2019-02-27 | SELL | 9,000 | $65 | $585K |
| Biller Scott | Chief Scientific Officer | 2018-11-05 | SELL | 3,000 | $69.69 | $209.1K |
| Biller Scott | Chief Scientific Officer | 2018-10-05 | SELL | 3,000 | $69.79 | $209.4K |
| Alenson Carman | Principal Accounting Officer | 2018-09-28 | SELL | 152 | $76.45 | $11.6K |
| MARAGANORE JOHN | Director | 2018-09-12 | SELL | 27,717 | $72.23 | $2002K |
| Alenson Carman | Principal Accounting Officer | 2018-09-05 | SELL | 312 | $83 | $25.9K |
| Biller Scott | Chief Scientific Officer | 2018-09-05 | SELL | 3,000 | $83.07 | $249.2K |
| Bowden Christopher | Chief Medical Officer | 2018-08-30 | SELL | 2,000 | $80.03 | $160.1K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-08-24 | SELL | 2,050 | $74.92 | $153.6K |
| Biller Scott | Chief Scientific Officer | 2018-08-06 | SELL | 3,000 | $80.11 | $240.3K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-07-25 | SELL | 2,050 | $84.58 | $173.4K |
| Bowden Christopher | Chief Medical Officer | 2018-07-10 | SELL | 2,000 | $86.76 | $173.5K |
| Alenson Carman | Principal Accounting Officer | 2018-07-09 | SELL | 272 | $84.94 | $23.1K |
| Biller Scott | Chief Scientific Officer | 2018-07-05 | SELL | 3,000 | $83.5 | $250.5K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-06-22 | SELL | 2,050 | $97.58 | $200K |
| Foster-Cheek Kaye I | Director | 2018-06-14 | SELL | 9,000 | $93.55 | $842K |
| Bowden Christopher | Chief Medical Officer | 2018-06-12 | SELL | 2,000 | $92.89 | $185.8K |
| Biller Scott | Chief Scientific Officer | 2018-06-05 | SELL | 3,000 | $93.37 | $280.1K |
| Schenkein David P | CEO | 2018-06-01 | SELL | 13,000 | $95.35 | $1239.6K |
| Schenkein David P | CEO | 2018-05-30 | SELL | 45,626 | $90.07 | $4109.5K |
| Schenkein David P | CEO | 2018-05-23 | SELL | 49,374 | $90.4 | $4463.4K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-05-23 | SELL | 2,050 | $85.76 | $175.8K |
| Biller Scott | Chief Scientific Officer | 2018-05-23 | SELL | 15,177 | $90 | $1365.9K |
| Bowden Christopher | Chief Medical Officer | 2018-05-11 | SELL | 2,000 | $85 | $170K |
| Bowden Christopher | Chief Medical Officer | 2018-05-08 | SELL | 2,000 | $81.38 | $162.8K |
| Biller Scott | Chief Scientific Officer | 2018-05-07 | SELL | 3,000 | $81.81 | $245.4K |
| Schenkein David P | CEO | 2018-05-01 | SELL | 13,000 | $83.04 | $1079.5K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-04-23 | SELL | 2,050 | $85.95 | $176.2K |
| Bowden Christopher | Chief Medical Officer | 2018-04-12 | SELL | 2,000 | $85.1 | $170.2K |
| Biller Scott | Chief Scientific Officer | 2018-04-05 | SELL | 3,000 | $75.2 | $225.6K |
| Schenkein David P | CEO | 2018-04-02 | SELL | 13,000 | $77.72 | $1010.4K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-03-22 | SELL | 2,050 | $84.65 | $173.5K |
| Foster-Cheek Kaye I | Director | 2018-03-19 | SELL | 6,800 | $81.97 | $557.4K |
| Scadden David | Director | 2018-03-16 | BUY | 200 | $83.44 | $16.7K |
| Bowden Christopher | Chief Medical Officer | 2018-03-14 | SELL | 2,000 | $82.33 | $164.7K |
| Biller Scott | Chief Scientific Officer | 2018-03-05 | SELL | 3,000 | $83.08 | $249.2K |
| Schenkein David P | CEO | 2018-03-01 | SELL | 13,000 | $81.09 | $1054.2K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-02-22 | SELL | 2,050 | $78.63 | $161.2K |
| Bowden Christopher | Chief Medical Officer | 2018-02-16 | SELL | 2,000 | $77.65 | $155.3K |
| Biller Scott | Chief Scientific Officer | 2018-02-05 | SELL | 3,000 | $76.04 | $228.1K |
| Bowden Christopher | Chief Medical Officer | 2018-02-01 | SELL | 2,000 | $78.75 | $157.5K |
| Schenkein David P | CEO | 2018-02-01 | SELL | 13,000 | $78.75 | $1023.8K |
| Schenkein David P | CEO | 2018-01-26 | SELL | 23,572 | $81.09 | $1911.5K |
| Schenkein David P | CEO | 2018-01-24 | SELL | 46,408 | $80.01 | $3713.1K |
| Schenkein David P | CEO | 2018-01-24 | SELL | 20 | $80.01 | $1.6K |
| CELGENE CORP /DE/ | 10% Owner | 2018-01-23 | BUY | 851,154 | $67 | $57027.3K |
| Hoerter Steven L. | Chief Commercial Officer | 2018-01-23 | SELL | 25,000 | $74.83 | $1870.8K |
| CELGENE CORP /DE/ | 10% Owner | 2018-01-23 | BUY | 851,154 | $67 | $57027.3K |
| Schenkein David P | CEO | 2018-01-16 | SELL | 53,000 | $73.16 | $3877.5K |
| Alenson Carman | Principal Accounting Officer | 2018-01-12 | SELL | 2,150 | $75 | $161.3K |
| Biller Scott | Chief Scientific Officer | 2018-01-10 | SELL | 3,000 | $65 | $195K |
| Cantley Lewis Clayton Jr. | Director | 2017-12-07 | SELL | 3,838 | $59.37 | $227.9K |
| Schenkein David P | CEO | 2017-12-01 | SELL | 6,000 | $61.55 | $369.3K |
| Biller Scott | Chief Scientific Officer | 2017-12-01 | SELL | 2,146 | $60.79 | $130.5K |
| Cantley Lewis Clayton Jr. | Director | 2017-11-14 | SELL | 4,000 | $60.88 | $243.5K |
| Biller Scott | Chief Scientific Officer | 2017-11-01 | SELL | 2,146 | $62.69 | $134.5K |
| Schenkein David P | CEO | 2017-11-01 | SELL | 6,000 | $63.85 | $383.1K |
| Cantley Lewis Clayton Jr. | Director | 2017-10-17 | SELL | 4,000 | $71.1 | $284.4K |
| Biller Scott | Chief Scientific Officer | 2017-10-04 | SELL | 10,470 | $70 | $732.9K |
| Schenkein David P | CEO | 2017-10-04 | SELL | 80,000 | $70.14 | $5611.2K |
| Biller Scott | Chief Scientific Officer | 2017-10-02 | SELL | 2,146 | $67.23 | $144.3K |
| Schenkein David P | CEO | 2017-10-02 | SELL | 6,000 | $66.76 | $400.6K |
| Schenkein David P | CEO | 2017-09-18 | SELL | 35,000 | $67.12 | $2349.2K |
| Cantley Lewis Clayton Jr. | Director | 2017-09-14 | SELL | 4,000 | $65.59 | $262.4K |
| Bowden Christopher | Chief Medical Officer | 2017-09-11 | SELL | 6,000 | $65 | $390K |
| Biller Scott | Chief Scientific Officer | 2017-09-11 | SELL | 15,000 | $65 | $975K |
| Biller Scott | Chief Scientific Officer | 2017-09-01 | SELL | 2,146 | $61.99 | $133K |
| Schenkein David P | CEO | 2017-09-01 | SELL | 6,000 | $62.2 | $373.2K |
| Cantley Lewis Clayton Jr. | Director | 2017-08-23 | SELL | 4,000 | $56.85 | $227.4K |
| Biller Scott | Chief Scientific Officer | 2017-08-02 | SELL | 23,146 | $59.6 | $1379.5K |
| Schenkein David P | CEO | 2017-08-02 | SELL | 27,000 | $59.95 | $1618.7K |
| Cantley Lewis Clayton Jr. | Director | 2017-07-20 | SELL | 9,000 | $56.36 | $507.2K |
| Biller Scott | Chief Scientific Officer | 2017-07-07 | SELL | 2,146 | $55 | $118K |
| Schenkein David P | CEO | 2017-07-03 | SELL | 3,000 | $51.18 | $153.5K |
| Biller Scott | Chief Scientific Officer | 2017-06-21 | SELL | 4,292 | $55 | $236.1K |
| Cantley Lewis Clayton Jr. | Director | 2017-06-14 | SELL | 2,000 | $50.87 | $101.7K |
| Schenkein David P | CEO | 2017-06-07 | SELL | 3,000 | $50.02 | $150.1K |
| Cantley Lewis Clayton Jr. | Director | 2017-05-25 | SELL | 2,036 | $47.1 | $95.9K |
| Schenkein David P | CEO | 2017-05-01 | SELL | 3,000 | $50.06 | $150.2K |
| Celgene European Investment Co | 10% Owner | 2017-04-24 | BUY | 624,575 | $49.5 | $30916.5K |
| Cantley Lewis Clayton Jr. | Director | 2017-04-18 | SELL | 5,090 | $54.37 | $276.7K |
| Biller Scott | Chief Scientific Officer | 2017-04-03 | SELL | 2,146 | $58.03 | $124.5K |
| Schenkein David P | CEO | 2017-04-03 | SELL | 3,000 | $58.62 | $175.9K |
| Cantley Lewis Clayton Jr. | Director | 2017-03-23 | SELL | 2,036 | $53.11 | $108.1K |
| Biller Scott | Chief Scientific Officer | 2017-03-20 | SELL | 6,438 | $55 | $354.1K |
| NELSEN ROBERT | Director | 2017-03-06 | SELL | 40,599 | $50.84 | $2064.1K |
| Schenkein David P | CEO | 2017-03-01 | SELL | 3,000 | $50.47 | $151.4K |
| NELSEN ROBERT | Director | 2017-02-28 | SELL | 243,082 | $49.36 | $11998.5K |
| NELSEN ROBERT | Director | 2017-02-23 | SELL | 135,364 | $49.37 | $6682.9K |
| Schenkein David P | CEO | 2017-02-16 | SELL | 6,000 | $50.01 | $300.1K |
| Biller Scott | Chief Scientific Officer | 2016-11-14 | SELL | 32,500 | $65 | $2112.5K |
| Biller Scott | Chief Scientific Officer | 2016-11-10 | SELL | 5,000 | $60 | $300K |
| Cantley Lewis Clayton Jr. | Director | 2016-10-27 | SELL | 2,504 | $48.94 | $122.5K |
| Biller Scott | Chief Scientific Officer | 2016-10-05 | SELL | 5,000 | $55 | $275K |
| Cantley Lewis Clayton Jr. | Director | 2016-09-28 | SELL | 2,504 | $54.08 | $135.4K |
| Biller Scott | Chief Scientific Officer | 2016-09-20 | SELL | 5,000 | $50 | $250K |
| Cantley Lewis Clayton Jr. | Director | 2016-08-30 | SELL | 2,504 | $37.31 | $93.4K |
| Cantley Lewis Clayton Jr. | Director | 2016-07-26 | SELL | 2,504 | $42.8 | $107.2K |
| Cantley Lewis Clayton Jr. | Director | 2016-06-28 | SELL | 2,504 | $41.88 | $104.9K |
| Biller Scott | Chief Scientific Officer | 2016-06-08 | SELL | 27,500 | $65 | $1787.5K |
| Cantley Lewis Clayton Jr. | Director | 2016-05-26 | SELL | 2,504 | $51.69 | $129.4K |
| Cantley Lewis Clayton Jr. | Director | 2016-04-26 | SELL | 2,504 | $53.44 | $133.8K |
| Cantley Lewis Clayton Jr. | Director | 2016-03-30 | SELL | 2,504 | $37.19 | $93.1K |
| Cantley Lewis Clayton Jr. | Director | 2016-02-26 | SELL | 2,504 | $37.9 | $94.9K |
| Cantley Lewis Clayton Jr. | Director | 2016-01-29 | SELL | 2,504 | $42.93 | $107.5K |
| Cantley Lewis Clayton Jr. | Director | 2015-12-29 | SELL | 10,664 | $64.93 | $692.4K |
| Higgons John Duncan | COO | 2015-12-15 | SELL | 20,000 | $50.09 | $1001.8K |
| Biller Scott | Chief Scientific Officer | 2015-11-30 | SELL | 5,500 | $65.99 | $362.9K |
| Cantley Lewis Clayton Jr. | Director | 2015-11-17 | SELL | 9,408 | $59.83 | $562.9K |
| Cantley Lewis Clayton Jr. | Director | 2015-11-17 | SELL | 9,704 | $59.87 | $581K |
| Higgons John Duncan | COO | 2015-11-16 | SELL | 20,000 | $61.51 | $1230.2K |
| Biller Scott | Chief Scientific Officer | 2015-11-02 | SELL | 5,500 | $77.12 | $424.2K |
| Schenkein David P | CEO | 2015-10-27 | SELL | 4,000 | $80.26 | $321K |
| Cantley Lewis Clayton Jr. | Director | 2015-10-23 | SELL | 9,704 | $61.16 | $593.5K |
| Higgons John Duncan | COO | 2015-10-15 | SELL | 20,000 | $71.04 | $1420.8K |
| Biller Scott | Chief Scientific Officer | 2015-09-30 | SELL | 5,500 | $70.44 | $387.4K |
| Cantley Lewis Clayton Jr. | Director | 2015-09-25 | SELL | 9,704 | $83.25 | $807.9K |
| Goddard Glenn | Senior Vice President, Finance | 2015-09-24 | SELL | 6,000 | $85.97 | $515.8K |
| Higgons John Duncan | COO | 2015-09-15 | SELL | 20,000 | $91.11 | $1822.2K |
| Cantley Lewis Clayton Jr. | Director | 2015-08-18 | SELL | 9,704 | $94.94 | $921.3K |
| Higgons John Duncan | COO | 2015-08-17 | SELL | 20,000 | $92.24 | $1844.8K |
| Biller Scott | Chief Scientific Officer | 2015-08-10 | SELL | 5,500 | $100 | $550K |
| Schenkein David P | CEO | 2015-08-03 | SELL | 8,000 | $110.6 | $884.8K |
| Goddard Glenn | Senior Vice President, Finance | 2015-07-23 | SELL | 7,000 | $120.45 | $843.2K |
| Biller Scott | Chief Scientific Officer | 2015-07-20 | SELL | 5,500 | $113.87 | $626.3K |
| Goddard Glenn | Senior Vice President, Finance | 2015-07-17 | SELL | 13,000 | $113.71 | $1478.2K |
| Cantley Lewis Clayton Jr. | Director | 2015-07-16 | SELL | 9,704 | $114.28 | $1109K |
| Higgons John Duncan | COO | 2015-07-16 | SELL | 20,000 | $114.02 | $2280.4K |
| Cantley Lewis Clayton Jr. | Director | 2015-06-25 | SELL | 9,704 | $105.13 | $1020.2K |
| Higgons John Duncan | COO | 2015-06-15 | SELL | 7,000 | $105.23 | $736.6K |
| Biller Scott | Chief Scientific Officer | 2015-06-08 | SELL | 5,500 | $121.85 | $670.2K |
| Schenkein David P | CEO | 2015-06-01 | SELL | 13,000 | $120.67 | $1568.7K |
| Bowden Christopher | Chief Medical Officer | 2015-06-01 | SELL | 5,000 | $120.67 | $603.4K |
| Schenkein David P | CEO | 2015-05-27 | SELL | 8,929 | $120.05 | $1071.9K |
| Goddard Glenn | Senior Vice President, Finance | 2015-05-27 | SELL | 2,171 | $120.05 | $260.6K |
| Cantley Lewis Clayton Jr. | Director | 2015-05-20 | SELL | 9,704 | $116.64 | $1131.9K |
| Higgons John Duncan | COO | 2015-05-15 | SELL | 7,417 | $112.89 | $837.3K |
| Schenkein David P | CEO | 2015-05-12 | SELL | 5,200 | $110.02 | $572.1K |
| Schenkein David P | CEO | 2015-05-08 | SELL | 3,900 | $101.32 | $395.1K |
| Biller Scott | Chief Scientific Officer | 2015-05-07 | SELL | 11,000 | $96.98 | $1066.8K |
| Schenkein David P | CEO | 2015-05-01 | SELL | 3,900 | $93.63 | $365.2K |
| Cantley Lewis Clayton Jr. | Director | 2015-04-24 | SELL | 9,704 | $105.15 | $1020.4K |
| Higgons John Duncan | COO | 2015-04-15 | SELL | 6,583 | $99.54 | $655.3K |
| Schenkein David P | CEO | 2015-04-13 | SELL | 3,900 | $100.03 | $390.1K |
| Schenkein David P | CEO | 2015-04-01 | SELL | 3,900 | $92.54 | $360.9K |
| Cantley Lewis Clayton Jr. | Director | 2015-03-27 | SELL | 9,704 | $93.58 | $908.1K |
| Higgons John Duncan | COO | 2015-03-16 | SELL | 7,000 | $106.24 | $743.7K |
| Goddard Glenn | Senior Vice President, Finance | 2015-03-16 | SELL | 10,000 | $106.24 | $1062.4K |
| Biller Scott | Chief Scientific Officer | 2015-03-16 | SELL | 5,500 | $106.81 | $587.5K |
| Schenkein David P | CEO | 2015-03-05 | SELL | 2,600 | $110.16 | $286.4K |
| Schenkein David P | CEO | 2015-03-02 | SELL | 7,800 | $107.05 | $835K |
| Goddard Glenn | Senior Vice President, Finance | 2015-02-13 | SELL | 1,316 | $120.31 | $158.3K |
| Schenkein David P | CEO | 2015-02-13 | SELL | 1,471 | $120.22 | $176.8K |
| Goddard Glenn | Senior Vice President, Finance | 2015-02-11 | SELL | 16,513 | $107.12 | $1768.9K |
| Schenkein David P | CEO | 2015-02-02 | SELL | 10,400 | $114.31 | $1188.8K |
| Biller Scott | Chief Scientific Officer | 2015-01-02 | SELL | 4,500 | $110.08 | $495.4K |
| Schenkein David P | CEO | 2015-01-02 | SELL | 13,000 | $110.08 | $1431K |
| Higgons John Duncan | COO | 2015-01-02 | SELL | 12,000 | $110.08 | $1321K |
| Higgons John Duncan | COO | 2015-01-02 | SELL | 12,000 | $110.08 | $1321K |
| Celgene European Investment Co | 10% Owner | 2014-12-16 | BUY | 228,645 | $110.75 | $25322.4K |
| MARAGANORE JOHN | Director | 2014-12-16 | BUY | 1,806 | $110.75 | $200K |
| Schenkein David P | CEO | 2014-12-01 | SELL | 13,000 | $97.03 | $1261.4K |
| Higgons John Duncan | COO | 2014-12-01 | SELL | 12,000 | $97.03 | $1164.4K |
| Biller Scott | Chief Scientific Officer | 2014-12-01 | SELL | 4,500 | $97.03 | $436.6K |
| Schenkein David P | CEO | 2014-11-03 | SELL | 13,000 | $81.71 | $1062.2K |
| Goddard Glenn | Senior Vice President, Finance | 2014-11-03 | SELL | 2,000 | $81.71 | $163.4K |
| Higgons John Duncan | COO | 2014-11-03 | SELL | 13,000 | $81.71 | $1062.2K |
| Biller Scott | Chief Scientific Officer | 2014-11-03 | SELL | 4,500 | $81.71 | $367.7K |
| Schenkein David P | CEO | 2014-10-01 | SELL | 13,000 | $60.07 | $780.9K |
| Higgons John Duncan | COO | 2014-10-01 | SELL | 13,000 | $60.07 | $780.9K |
| Biller Scott | Chief Scientific Officer | 2014-10-01 | SELL | 4,500 | $60.07 | $270.3K |
| Goddard Glenn | Senior Vice President, Finance | 2014-10-01 | SELL | 1,500 | $60.07 | $90.1K |
| Goddard Glenn | Senior Vice President, Finance | 2014-09-26 | SELL | 17,500 | $56.53 | $989.3K |
| Schenkein David P | CEO | 2014-09-26 | SELL | 60,000 | $62.68 | $3760.8K |
| Biller Scott | Chief Scientific Officer | 2014-09-19 | SELL | 37,996 | $50.45 | $1916.9K |
| Biller Scott | Chief Scientific Officer | 2014-09-02 | SELL | 4,500 | $46.3 | $208.4K |
| Goddard Glenn | Senior Vice President, Finance | 2014-09-02 | SELL | 10,000 | $46.3 | $463K |
| Schenkein David P | CEO | 2014-09-02 | SELL | 13,000 | $46.3 | $601.9K |
| Higgons John Duncan | COO | 2014-09-02 | SELL | 13,000 | $46.3 | $601.9K |
| Higgons John Duncan | COO | 2014-08-26 | SELL | 5,000 | $45.05 | $225.3K |
| Schenkein David P | CEO | 2014-08-11 | SELL | 4,530 | $40.17 | $182K |
| Schenkein David P | CEO | 2014-08-01 | SELL | 8,470 | $39.17 | $331.8K |
| Higgons John Duncan | COO | 2014-08-01 | SELL | 7,000 | $39.09 | $273.6K |
| Biller Scott | Chief Scientific Officer | 2014-08-01 | SELL | 4,500 | $39.09 | $175.9K |
| Schenkein David P | CEO | 2014-07-01 | SELL | 13,000 | $46.52 | $604.8K |
| Goddard Glenn | Senior Vice President, Finance | 2014-07-01 | SELL | 3,500 | $46.52 | $162.8K |
| Higgons John Duncan | COO | 2014-07-01 | SELL | 12,000 | $46.52 | $558.2K |
| Biller Scott | Chief Scientific Officer | 2014-07-01 | SELL | 4,500 | $46.52 | $209.3K |
| MARAGANORE JOHN | Director | 2014-06-23 | BUY | 2,300 | $43.98 | $101.2K |
| Biller Scott | Chief Scientific Officer | 2014-06-20 | SELL | 2,004 | $50.05 | $100.3K |
| Higgons John Duncan | COO | 2014-06-13 | SELL | 5,000 | $45.27 | $226.4K |
| Higgons John Duncan | COO | 2014-06-03 | SELL | 7,000 | $34.47 | $241.3K |
| Biller Scott | Chief Scientific Officer | 2014-06-02 | SELL | 4,500 | $33.76 | $151.9K |
| Higgons John Duncan | COO | 2014-05-06 | SELL | 5,000 | $45.73 | $228.7K |
| Goddard Glenn | Senior Vice President, Finance | 2014-05-01 | SELL | 2,000 | $42.39 | $84.8K |
| Higgons John Duncan | COO | 2014-05-01 | SELL | 7,000 | $42.39 | $296.7K |
| Biller Scott | Chief Scientific Officer | 2014-05-01 | SELL | 4,500 | $42.39 | $190.8K |
| MARAGANORE JOHN | Director | 2014-04-29 | BUY | 2,250 | $44 | $99K |
| Celgene European Investment Co | 10% Owner | 2014-04-29 | BUY | 294,800 | $44 | $12971.2K |
| Higgons John Duncan | COO | 2014-04-07 | SELL | 3,000 | $45.17 | $135.5K |
| Goddard Glenn | Senior Vice President, Finance | 2014-04-07 | SELL | 2,000 | $45.17 | $90.3K |
| Goddard Glenn | Senior Vice President, Finance | 2014-04-01 | SELL | 4,000 | $38.08 | $152.3K |
| Higgons John Duncan | COO | 2014-04-01 | SELL | 12,000 | $38.08 | $457K |
| Biller Scott | Chief Scientific Officer | 2014-04-01 | SELL | 4,500 | $38.08 | $171.4K |
| Higgons John Duncan | COO | 2014-03-07 | SELL | 14,646 | $41.41 | $606.5K |
| Goddard Glenn | Senior Vice President, Finance | 2014-03-07 | SELL | 17,468 | $42.11 | $735.6K |
| Higgons John Duncan | COO | 2014-03-03 | SELL | 8,000 | $29.85 | $238.8K |
| Biller Scott | Chief Scientific Officer | 2014-03-03 | SELL | 6,000 | $29.85 | $179.1K |
| Higgons John Duncan | COO | 2014-02-18 | SELL | 2,354 | $35.06 | $82.5K |
| Goddard Glenn | Senior Vice President, Finance | 2014-02-18 | SELL | 3,532 | $35.06 | $123.8K |
| Goddard Glenn | Senior Vice President, Finance | 2014-02-10 | SELL | 6,000 | $30.44 | $182.6K |
| Higgons John Duncan | COO | 2014-02-03 | SELL | 8,000 | $25.97 | $207.8K |
| Biller Scott | Chief Scientific Officer | 2014-02-03 | SELL | 6,000 | $25.97 | $155.8K |
| Goddard Glenn | Senior Vice President, Finance | 2014-01-27 | SELL | 7,000 | $26.29 | $184K |
| Biller Scott | Chief Scientific Officer | 2014-01-21 | SELL | 6,000 | $34.71 | $208.3K |
| Higgons John Duncan | COO | 2014-01-21 | SELL | 12,000 | $34.71 | $416.5K |
| Goddard Glenn | Senior Vice President, Finance | 2014-01-21 | SELL | 10,000 | $34.71 | $347.1K |
| Celgene European Investment Co | 10% Owner | 2013-07-29 | BUY | 708,333 | $18 | $12750K |
| Tessier-Lavigne Marc | Director | 2013-07-24 | BUY | 55,555 | $18 | $1000K |
| MARAGANORE JOHN | Director | 2013-07-24 | BUY | 8,333 | $18 | $150K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked